Orange Book product · Brand (NDA)
PATADAY TWICE DAILY RELIEF
OLOPATADINE HYDROCHLORIDE
At a glance
Dec 18, 1996
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 18, 1996
29 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
OLOPATADINE HYDROCHLORIDE
Strength
EQ 0.1% BASE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
NDA 020688
Product number
001
Marketing status
OTC
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2015PATADAY ONCE DAILY RELIEFBrand (NDA)
NDA 206276 · ALCON LABS INC
- 2008PATANASEBrand (NDA)
NDA 021861 · NOVARTIS
- 2004PATADAY ONCE DAILY RELIEFBrand (NDA)
NDA 021545 · ALCON LABS INC
- 2026OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213514 · GLAND
- 2025OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217051 · FDC LTD
- 2025OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 219557 · GLENMARK PHARMS
- 2024OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215006 · SOMERSET
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213757 · HIKMA
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204620 · RISING
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209752 · GLAND
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208637 · FLORIDA
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210901 · AMNEAL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

